Effect of integrated hepatitis C virus treatment on psychological distress in people with substance use disorders
Abstract People with substance use disorders (SUD) have a high prevalence of chronic hepatitis C virus (HCV) infection and mental health disorders. We aimed to assess the impact of integrated HCV treatment on psychological distress measured by Hopkins-symptom-checklist-10 (SCL-10). This multi-center...
Main Authors: | Christer F. Aas, Jørn Henrik Vold, Fatemeh Chalabianloo, Else-Marie Løberg, Aaron G. Lim, Peter Vickerman, Kjell Arne Johansson, Lars Thore Fadnes |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-01-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-024-51336-9 |
Similar Items
-
Changes in substance use during outpatient treatment for substance use disorders: a prospective Norwegian cohort study from 2016 to 2020
by: Jørn Henrik Vold, et al.
Published: (2021-09-01) -
Integrated care of severe infectious diseases to people with substance use disorders; a systematic review
by: Jørn Henrik Vold, et al.
Published: (2019-04-01) -
The efficacy of integrated hepatitis C virus treatment in relieving fatigue in people who inject drugs: a randomized controlled trial
by: Jørn Henrik Vold, et al.
Published: (2023-04-01) -
Attention-deficit/hyperactivity disorder (ADHD) symptoms and their relation to diagnosed ADHD, sociodemographic characteristics, and substance use among patients receiving opioid agonist therapy: a Norwegian cohort study
by: Jørn Henrik Vold, et al.
Published: (2023-06-01) -
Impact of clinical and sociodemographic factors on fatigue among patients with substance use disorder: a cohort study from Norway for the period 2016–2020
by: Jørn Henrik Vold, et al.
Published: (2020-12-01)